Conformai external beam treatment of prostate cancer

[1]  T E Schultheiss,et al.  Conformal technique dose escalation for prostate cancer: biochemical evidence of improved cancer control with higher doses in patients with pretreatment prostate-specific antigen > or = 10 NG/ML. , 1996, International journal of radiation oncology, biology, physics.

[2]  T E Schultheiss,et al.  Lateral rectal shielding reduces late rectal morbidity following high dose three-dimensional conformal radiation therapy for clinically localized prostate cancer: further evidence for a significant dose effect. , 1996, International journal of radiation oncology, biology, physics.

[3]  A. Hanlon,et al.  Young patients with prostate cancer have an outcome justifying their treatment with external beam radiation. , 1996, International journal of radiation oncology, biology, physics.

[4]  G. Hanks,et al.  Prostate carcinoma patients upstaged by imaging and treated with irradiation: An outcome‐based analysis , 1996, Cancer.

[5]  T. Schultheiss,et al.  Clinical and biochemical evidence of control of prostate cancer at 5 years after external beam radiation. , 1995, The Journal of urology.

[6]  A Pollack,et al.  Prostate-specific antigen and radiation therapy for clinically localized prostate cancer. , 1995, International journal of radiation oncology, biology, physics.

[7]  A. Pollack,et al.  Radiation therapy for T1 and T2 prostate cancer: prostate-specific antigen and disease outcome. , 1995, Urology.

[8]  M. Hunt,et al.  Localized prostate cancer treated by external-beam radiotherapy alone: serum prostate-specific antigen--driven outcome analysis. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  A. Zietman,et al.  Radical radiation therapy in the management of prostatic adenocarcinoma: the initial prostate specific antigen value as a predictor of treatment outcome. , 1994, The Journal of urology.

[10]  T. Stamey,et al.  The value of serial prostate specific antigen determinations 5 years after radiotherapy: steeply increasing values characterize 80% of patients. , 1993, The Journal of urology.

[11]  A W Partin,et al.  Serum PSA after anatomic radical prostatectomy. The Johns Hopkins experience after 10 years. , 1993, The Urologic clinics of North America.

[12]  A. V. von Eschenbach,et al.  Prostate‐specific antigen. An important marker for prostate cancer treated by external beam radiation therapy , 1993, Cancer.

[13]  Samuel Hellman,et al.  Important advances in oncology , 1991 .

[14]  J. Lawless.  Statistical Models and Methods for Lifetime Data , 1983 .

[15]  J. Kalbfleisch,et al.  The Statistical Analysis of Failure Time Data , 1980 .

[16]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .

[17]  A. Hanlon,et al.  Chronic rectal bleeding after high-dose conformal treatment of prostate cancer warrants modification of existing morbidity scales. , 1997, International journal of radiation oncology, biology, physics.

[18]  A. Hanlon,et al.  Rectal bleeding after conformal 3D treatment of prostate cancer: time to occurrence, response to treatment and duration of morbidity. , 1997, International journal of radiation oncology, biology, physics.

[19]  A. Hanlon,et al.  1053 Preservation of sexual function in young prostate cancer patients after radiation therapy: A positive factor in choice of a treatment modality , 1996 .

[20]  T. Schultheiss,et al.  Observations of pretreatment prostate-specific antigen doubling time in 107 patients referred for definitive radiotherapy. , 1995, International journal of radiation oncology, biology, physics.

[21]  A. Hanlon,et al.  1057 Factors related to late GI and GU complications in conformal and conventional radiation treatment of cancer of the prostate , 1995 .

[22]  W. R. Lee,et al.  98 Young patients with prostate cancer have an outcome justifying their acceptance for external beam treatment , 1995 .

[23]  A. Zietman,et al.  Long-term outcome for men with prostate cancer treated with radiation as solo therapy , 1994 .

[24]  W. R. Lee,et al.  Response to 'only 20% of irradiated prostate cancer patients are cured and the remainder may be made worse , 1994 .

[25]  Hanks Ge.  Treatment of early stage prostate cancer: radiotherapy. , 1994 .

[26]  G E Hanks,et al.  Conformal static field radiation therapy treatment of early prostate cancer versus non-conformal techniques: a reduction in acute morbidity. , 1992, International journal of radiation oncology, biology, physics.

[27]  G E Hanks,et al.  Conformal static field therapy for low volume low grade prostate cancer with rigid immobilization. , 1991, International journal of radiation oncology, biology, physics.

[28]  P. Walsh.  Radical retropubic prostatectomy with reduced morbidity: an anatomic approach. , 1988, NCI monographs : a publication of the National Cancer Institute.